Clinical experience and choice of drug therapy for human immunodeficiency virus disease

Clinical Infectious Diseases

Volumn 28, Issue 1, 1999, Pages 14-22

  Brosgart, Carol L ^a   Mitchell, Thomas F ^a,b   Coleman, Rebecca L ^a   Dyner, Toby ^a   Stephenson, Kathryn E ^a   Abrams, Donald I ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMITRIPTYLINE; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIRETROVIRUS AGENT; AZITHROMYCIN; CAPSAICIN DERIVATIVE; CLARITHROMYCIN; CLOTRIMAZOLE; COTRIMOXAZOLE; DAPSONE; DIDANOSINE; FLUCONAZOLE; GANCICLOVIR; GRANULOCYTE COLONY STIMULATING FACTOR; INDINAVIR; KETOCONAZOLE; LAMIVUDINE; MEXILETINE; NARCOTIC ANALGESIC AGENT; NUCLEOSIDE ANALOG; PENTAMIDINE; PYRIMETHAMINE; RIFABUTIN; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; UNINDEXED DRUG; ZIDOVUDINE;

ARTICLE; CYTOMEGALOVIRUS INFECTION; DRUG CHOICE; GENERAL PRACTITIONER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICAL SPECIALIST; MYCOBACTERIOSIS; MYCOSIS; NEUTROPENIA; NURSE PRACTITIONER; OPPORTUNISTIC INFECTION; PERIPHERAL NEUROPATHY; PHYSICIAN ASSISTANT; PNEUMOCYSTIS PNEUMONIA; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROPHYLAXIS; UNITED STATES;

EID: 0033059377     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/515081     Document Type: Article

References (34)

1. Soloway B. Primary care and specialty care in the age of HAART. AIDS Clinical Care 1997;9:37-9.
2. Volberding PA. Improving the outcomes of care for patients with human immunodeficiency virus infection. N Engl J Med 1996;334:729-31.
3. Curtis JR, Paauw DS, Wenrich MD, Carline JD, Ramsey PG. Physicians' ability to provide initial primary care to an HIV-infected patient. Arch Intern Med 1995;155:1613-8.
4. Shapiro MF, Greenfield S. Experience and outcomes in AIDS. JAMA 1992;268:2698-9.
5. Smith MD. Primary care and HIV disease. J Gen Intern Med 1991;6(suppl):S56-62.
6. Makadon HJ, Delbanco SF, Delbanco TL. Caring for people with AIDS and HIV infection in hospital-based primary care practice. J Gen Intern Med 1990;5:446-50.
7. Rothman DJ, Tynan EA. Advantages and disadvantages of special hospitals for patients with HIV infection: a report by the New York City Task Force on single-disease hospitals. N Engl J Med 1990;323:764-8.
8. Cotton DJ. Improving survival in acquired immunodeficiency syndrome: is experience everything? JAMA 1989;261:3016-7.
9. Northfelt DW, Hayward RA, Shapiro MF. The acquired immunodeficiency syndrome is a primary care disease. Ann Intern Med 1988;109:773-5.
10. Cooney TG. The AIDS epidemic and the general internist. J Gen Intern Med 1986;1:339-40.
11. Centers for Disease Control and Prevention. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. MMWR Morb Mortal Wkly Rep 1998;47(RR-5):43-82.
12. Centers for Disease Control and Prevention. Report of the NIH panel to define principles of therapy of HIV infection. MMWR Morb Mortal Wkly Rep 1998;47(RR-5):1-41.
13. Centers for Disease Control and Prevention. 1997 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons with human immunodeficiency virus. MMWR Morb Mortal Wkly Rep 1997;46(RR-12):1-49.
14. CAESAR Coordinating Committee. Randomized trial of addition of lamivudine or lamivudine plus lovirride to zidovudine-containing regimens for patients with HIV-1 infection: the CAESAR trial. Lancet 1997;349:1413-21.
15. Cameron B, Heath-Chiozzi M, Kravcik S, Mills R, Potthoff A, Henry D. Prolongation of life and prevention of AIDS in advanced HIV immunodeficiency with ritonavir [abstract no LB6a]. In: Program and abstracts of the 3rd Conference on Retroviruses and Opportunistic Infections (Washington, DC). Alexandria, VA: IDSA for the Foundation for Retrovirology and Human Health, 1996.
16. Hammer SM, Katzenstein DA, Hughes MD, et al. A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group 175 Study Team. N Engl J Med 1996;335:1081-90.
17. Hammer SM, Squires KE, Hughes MD, et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. N Engl J Med 1997;337:725-33.
18. Bennett CL, Garfinkle JB, Greenfield S, et al. The relation between hospital experience and in-hospital mortality for patients with AIDS-related PCP. JAMA 1989;261:2975-9.
19. Bennett CL, Adams J, Gertler P, et al. Relations between hospital experience and in-hospital mortality for patients with AIDS-related Pneumocystis carinii pneumonia: experience from 3,126 cases in New York City in 1987. J Acquir Immune Defic Syndr 1992;5:856-64.
20. Stone VE, Seage GR, Hertz T, Epstein AM. The relation between hospital experience and mortality for patients with AIDS. JAMA 1992;268:2655-61.
21. Kitahata MM, Koepsell TD, Deyo RA, Maxwell CL, Dodge WT, Wagner EH. Physicians' experience with the acquired immunodeficiency syndrome as a factor in patients' survival. N Engl J Med 1996;334:701-6.
22. Mitchell TF, Brosgart CL, Dyner T, et al. Community patterns of care for HIV disease: does clinical experience make a difference? [abstract no 255]. In: Program and abstracts of the 4th Conference on Retroviruses and Opportunistic Infections (Washington, DC). Alexandria, VA: IDSA for the Foundation for Retrovirology and Human Health, 1997:111.
23. Coleman RL, Brosgart CL, Mitchell TF, Dyner T, Gee L, Abrams DI. Antiretroviral prescribing patterns following introduction of protease inhibitors (PI) [abstract no 258]. In: Program and abstracts of the 4th Conference on Retroviruses and Opportunistic Infections (Washington, DC). Alexandria, VA: IDSA for the Foundation for Retrovirology and Human Health, 1997:112.
24. Jollis JG, DeLong ER, Peterson ED, et al. Outcome of acute myocardial infarction according to the specialty of the admitting physician. N Engl J Med 1996;335:1880-7.
25. Steinwachs DM, Wu AW, Skinner EA, Young Y. Asthma outcomes in managed health care: outcomes, management and quality improvement. Report submitted to Managed Health Care Association and Outcomes Management System Consortium. Bloomington, MN: Health Outcomes Institute, 1996.
26. Maerki SC, Luft HS, Hunt SS. Selecting categories of patients for regionalization: implications of the relationship between volume and outcome. Med Care 1986;24:148-58.
27. Luft HS, Hunt SS, Maerki SC. The volume-outcome relationship: practicemakes-perfect or selective-referral patterns? Health Serv Res 1987;22:157-82.
28. Markson LE, Leon LE, Turner BJ. Implications of generalists' slow adoption of zidovudine in clinical practice. Arch Intern Med 1994;154:1497-504.
29. Schroeder SA, Showstack JA. Financial incentives to perform medical procedures and laboratory tests: illustrative models of office practice. Med Care 1978;16:289-98.
30. Greenfield S, Nelson Ed, Zubkoff M, et al. Variations in resource utilization among medical specialties and systems of care: results from the Medical Outcomes Study. JAMA 1992;267:1624-30.
31. Welch WP, Miller ME, Welch HG, Fisher ES, Wennberg JE. Geographic variation in expenditures for physicians' services in the United States. N Engl J Med 1993;328:928-33.
32. Schroeder SA, Sandy LG. Specialty distribution of U.S. physicians - the invisible driver of health care costs. N Engl J Med 1993;328:961-3.
33. Ruane PJ, Ida J, Zakowski PC, Sokolov RJ, Uman SJ. Impact of newer antiretroviral therapies on inpatient and outpatient utilization of health care resources in patients with HIV [abstract no 262]. In: Program and abstracts of the 4th Conference on Retroviruses and Opportunistic Infections (Washington, DC). Alexandria, VA: IDSA for the Foundation for Retrovirology and Human Health, 1997:112.
34. Mouton Y, Alfandari S, Valette M, et al. Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centres. Federation National des Centres de Lutte contrete le SIDA. AIDS 1997;11:F101-5.